It targets the tumor suppressor genes PTEN, Tropomyosin alpha-1 chain (TPM1) and Programmed Cell Death 4 (PDCD4), thereby exhibiting oncogenic activity by promoting tumor cell proliferation and inhibition of apoptosis [25,29]. This evidence concerns the gene PDCD4 and neoplasm.